Altogether, these results suggested that blocking EphA2 impairs HCMV infection of glioblastoma cells and highlighted EphA2 as a potential therapeutic target to halt HCMV infection in glioblastoma cells. The gene discussed is EPHA2; the disease is cytomegalovirus infection.